Treatment of acute orofacial pain with lower cervical intramuscular bupivacaine injections

A 1-year retrospective review of 114 patients

Larry B. Mellick, Gary A. Mellick

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Aims: To describe 1 year's experience in treating orofacial pain with intramuscular injections of 0.5% bupivacaine bilateral to the spinous processes of the lower cervical vertebrae. Methods: A retrospective review of 2,517 emergency department patients with discharge diagnoses of a variety of orofacial pain conditions and 771 patients who were coded as having had an anesthetic injection between June 30, 2003 and July 1, 2004 was performed. The records of all adult patients who had undergone paraspinous intramuscular injection with bupivacaine for the treatment of an orofacial pain condition were extracted from these 2 databases and included in this retrospective review. Pain relief was reported in 2 different ways: (1) patients (n = 114) were placed in 1 of 4 orofacial pain relief categories based on common clinical experience and face validity and (2) pain relief was calculated based on patients' (n = 71) ratings of their pain on a numerical descriptor scale before and after treatment. Results: Lower cervical paraspinous intramuscular injections with bupivacaine were performed in 118 adult patients. Four charts were excluded from review because of missing or inadequate documentation. Pain relief (complete or clinical) occurred in 75 patients (66%), and partial orofacial pain relief in 32 patients (28%). No significant relief was reported in 7 patients (6%). Overall, some therapeutic response was reported in 107 of 114 patients (94%). Orofacial pain relief was rapid, with many patients reporting complete relief within 5 to 15 minutes. Conclusion: This is the first report of a large case series of emergency department patients whose orofacial pain conditions were treated with intramuscular injections of bupivacaine in the paraspinous muscles of the lower neck. The findings suggest that lower cervical paraspinous intramuscular injections with bupivacaine may prove to be a new therapeutic option for acute orofacial pain in the emergency department setting.

Original languageEnglish (US)
Pages (from-to)57-64
Number of pages8
JournalJournal of Orofacial Pain
Volume22
Issue number1
StatePublished - Dec 1 2008

Fingerprint

Facial Pain
Bupivacaine
Intramuscular Injections
Acute Pain
Therapeutics
Hospital Emergency Service
Pain
Neck Muscles
Cervical Vertebrae
Patient Discharge
Reproducibility of Results
Documentation
Anesthetics
Databases

Keywords

  • Allodynia
  • Bupivacaine
  • Cervical
  • Headache
  • Injection
  • Intramuscular
  • Orofacial
  • Pain
  • Paraspinous
  • Trigeminocervical

ASJC Scopus subject areas

  • Dentistry(all)
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Treatment of acute orofacial pain with lower cervical intramuscular bupivacaine injections : A 1-year retrospective review of 114 patients. / Mellick, Larry B.; Mellick, Gary A.

In: Journal of Orofacial Pain, Vol. 22, No. 1, 01.12.2008, p. 57-64.

Research output: Contribution to journalReview article

@article{dfac0fe380194646a30e2a5be9ce80c4,
title = "Treatment of acute orofacial pain with lower cervical intramuscular bupivacaine injections: A 1-year retrospective review of 114 patients",
abstract = "Aims: To describe 1 year's experience in treating orofacial pain with intramuscular injections of 0.5{\%} bupivacaine bilateral to the spinous processes of the lower cervical vertebrae. Methods: A retrospective review of 2,517 emergency department patients with discharge diagnoses of a variety of orofacial pain conditions and 771 patients who were coded as having had an anesthetic injection between June 30, 2003 and July 1, 2004 was performed. The records of all adult patients who had undergone paraspinous intramuscular injection with bupivacaine for the treatment of an orofacial pain condition were extracted from these 2 databases and included in this retrospective review. Pain relief was reported in 2 different ways: (1) patients (n = 114) were placed in 1 of 4 orofacial pain relief categories based on common clinical experience and face validity and (2) pain relief was calculated based on patients' (n = 71) ratings of their pain on a numerical descriptor scale before and after treatment. Results: Lower cervical paraspinous intramuscular injections with bupivacaine were performed in 118 adult patients. Four charts were excluded from review because of missing or inadequate documentation. Pain relief (complete or clinical) occurred in 75 patients (66{\%}), and partial orofacial pain relief in 32 patients (28{\%}). No significant relief was reported in 7 patients (6{\%}). Overall, some therapeutic response was reported in 107 of 114 patients (94{\%}). Orofacial pain relief was rapid, with many patients reporting complete relief within 5 to 15 minutes. Conclusion: This is the first report of a large case series of emergency department patients whose orofacial pain conditions were treated with intramuscular injections of bupivacaine in the paraspinous muscles of the lower neck. The findings suggest that lower cervical paraspinous intramuscular injections with bupivacaine may prove to be a new therapeutic option for acute orofacial pain in the emergency department setting.",
keywords = "Allodynia, Bupivacaine, Cervical, Headache, Injection, Intramuscular, Orofacial, Pain, Paraspinous, Trigeminocervical",
author = "Mellick, {Larry B.} and Mellick, {Gary A.}",
year = "2008",
month = "12",
day = "1",
language = "English (US)",
volume = "22",
pages = "57--64",
journal = "Journal of Orofacial Pain",
issn = "1064-6655",
publisher = "Quintessence Publishing Company",
number = "1",

}

TY - JOUR

T1 - Treatment of acute orofacial pain with lower cervical intramuscular bupivacaine injections

T2 - A 1-year retrospective review of 114 patients

AU - Mellick, Larry B.

AU - Mellick, Gary A.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Aims: To describe 1 year's experience in treating orofacial pain with intramuscular injections of 0.5% bupivacaine bilateral to the spinous processes of the lower cervical vertebrae. Methods: A retrospective review of 2,517 emergency department patients with discharge diagnoses of a variety of orofacial pain conditions and 771 patients who were coded as having had an anesthetic injection between June 30, 2003 and July 1, 2004 was performed. The records of all adult patients who had undergone paraspinous intramuscular injection with bupivacaine for the treatment of an orofacial pain condition were extracted from these 2 databases and included in this retrospective review. Pain relief was reported in 2 different ways: (1) patients (n = 114) were placed in 1 of 4 orofacial pain relief categories based on common clinical experience and face validity and (2) pain relief was calculated based on patients' (n = 71) ratings of their pain on a numerical descriptor scale before and after treatment. Results: Lower cervical paraspinous intramuscular injections with bupivacaine were performed in 118 adult patients. Four charts were excluded from review because of missing or inadequate documentation. Pain relief (complete or clinical) occurred in 75 patients (66%), and partial orofacial pain relief in 32 patients (28%). No significant relief was reported in 7 patients (6%). Overall, some therapeutic response was reported in 107 of 114 patients (94%). Orofacial pain relief was rapid, with many patients reporting complete relief within 5 to 15 minutes. Conclusion: This is the first report of a large case series of emergency department patients whose orofacial pain conditions were treated with intramuscular injections of bupivacaine in the paraspinous muscles of the lower neck. The findings suggest that lower cervical paraspinous intramuscular injections with bupivacaine may prove to be a new therapeutic option for acute orofacial pain in the emergency department setting.

AB - Aims: To describe 1 year's experience in treating orofacial pain with intramuscular injections of 0.5% bupivacaine bilateral to the spinous processes of the lower cervical vertebrae. Methods: A retrospective review of 2,517 emergency department patients with discharge diagnoses of a variety of orofacial pain conditions and 771 patients who were coded as having had an anesthetic injection between June 30, 2003 and July 1, 2004 was performed. The records of all adult patients who had undergone paraspinous intramuscular injection with bupivacaine for the treatment of an orofacial pain condition were extracted from these 2 databases and included in this retrospective review. Pain relief was reported in 2 different ways: (1) patients (n = 114) were placed in 1 of 4 orofacial pain relief categories based on common clinical experience and face validity and (2) pain relief was calculated based on patients' (n = 71) ratings of their pain on a numerical descriptor scale before and after treatment. Results: Lower cervical paraspinous intramuscular injections with bupivacaine were performed in 118 adult patients. Four charts were excluded from review because of missing or inadequate documentation. Pain relief (complete or clinical) occurred in 75 patients (66%), and partial orofacial pain relief in 32 patients (28%). No significant relief was reported in 7 patients (6%). Overall, some therapeutic response was reported in 107 of 114 patients (94%). Orofacial pain relief was rapid, with many patients reporting complete relief within 5 to 15 minutes. Conclusion: This is the first report of a large case series of emergency department patients whose orofacial pain conditions were treated with intramuscular injections of bupivacaine in the paraspinous muscles of the lower neck. The findings suggest that lower cervical paraspinous intramuscular injections with bupivacaine may prove to be a new therapeutic option for acute orofacial pain in the emergency department setting.

KW - Allodynia

KW - Bupivacaine

KW - Cervical

KW - Headache

KW - Injection

KW - Intramuscular

KW - Orofacial

KW - Pain

KW - Paraspinous

KW - Trigeminocervical

UR - http://www.scopus.com/inward/record.url?scp=39449139319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449139319&partnerID=8YFLogxK

M3 - Review article

VL - 22

SP - 57

EP - 64

JO - Journal of Orofacial Pain

JF - Journal of Orofacial Pain

SN - 1064-6655

IS - 1

ER -